nach oben

Erschienen in:

07.07.2021 | Herzrhythmusstörungen | Positionspapiere Zur Zeit gratis

Wearable-basierte Detektion von Arrhythmien

Positionspapier der Deutschen Gesellschaft für Kardiologie

verfasst von: Univ.-Prof. Dr. med. Christian Veltmann, Joachim R. Ehrlich, Ulrich M. Gassner, Benjamin Meder, Martin Möckel, Peter Radke, Eberhard Scholz, Hendrik Schneider, Christoph Stellbrink, David Duncker

Erschienen in: Die Kardiologie | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der technische Fortschritt in der Medizin hat dazu geführt, dass Herzfrequenz und Herzrhythmus nicht nur mittels professioneller Geräte aufgezeichnet werden können, sondern dies inzwischen auch vom Laien durch von jedermann erwerbbare sog. Wearables möglich ist. Unter Wearables versteht man direkt am Körper oder der Kleidung getragene elektronische Geräte, die in der Lage sind, biophysikalische Daten zu erheben. Zu den bekanntesten Wearables zählen Smartwatches, Armbänder und Brustgurte. Wearables sind in der Lage, Herzfrequenz, Pulskurven und das EKG zu erfassen. So können Wearables als Eventrekorder mit Symptom-getriggerter Aufzeichnung von Arrhythmien oder zum aktiven oder passiven Screening auf Vorhofflimmern genutzt werden. Dazu stehen prinzipiell 2 Verfahren zur Verfügung: die Elektrokardiographie und die Photoplethysmographie. Mit beiden Verfahren ist es inzwischen möglich, Software-unterstützt mit einer hohen Sensitivität und Spezifität Vorhofflimmern zu identifizieren. Ziel dieses Positionspapiers ist es, einen Überblick zur aktuellen Datenlage und zum Einsatz der Wearables bei der Detektion von symptomatischen und asymptomatischen Arrhythmien zu geben. Zusätzlich werden gesundheitsökonomische und auch rechtliche Aspekte im Umgang mit Wearables beleuchtet.

Andrade JG, Godin R, Nault I (2020) Large-scale implementation of a pragmatic atrial fibrillation screening program in Canadian community practice. Pacing Clin Electrophysiol 43:768–769. https://doi.org/10.1111/pace.13966CrossRefPubMed

Bansal A, Joshi R (2018) Portable out-of-hospital electrocardiography: a review of current technologies. J Arrhythmia 34:129–138. https://doi.org/10.1002/joa3.12035CrossRef

Barrett PM, Komatireddy R, Haaser S et al (2014) Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med 127(95):e11–95.e17. https://doi.org/10.1016/j.amjmed.2013.10.003CrossRef

Behzadi A, Shamloo AS, Mouratis K et al (2020) Feasibility and reliability of smartwatch to obtain 3‑lead electrocardiogram recordings. Sensors 20:5074. https://doi.org/10.3390/s20185074CrossRefPubMedCentral

Bonomi AG, Schipper F, Eerikäinen LM et al (2018) Atrial fibrillation detection using a novel cardiac ambulatory monitor based on photo-plethysmography at the wrist. J Am Heart Assoc 7:e9351. https://doi.org/10.1161/jaha.118.009351CrossRefPubMedPubMedCentral

Brasier N, Raichle CJ, Dörr M et al (2018) Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO). Europace 21:41–47. https://doi.org/10.1093/europace/euy176CrossRefPubMedCentral

Castelletti S, Dagradi F, Goulene K et al (2018) A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome. Int J Cardiol 266:89–94. https://doi.org/10.1016/j.ijcard.2018.03.097CrossRefPubMed

Chan P, Wong C, Poh YC et al (2016) Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J Am Heart Assoc. https://doi.org/10.1161/jaha.116.003428CrossRefPubMedPubMedCentral

Choi W, Kim S‑H, Lee W et al (2020) Comparison of continuous ECG monitoring by wearable patch device and conventional telemonitoring device. J Korean Med Sci 35:e363. https://doi.org/10.3346/jkms.2020.35.e363CrossRefPubMedPubMedCentral

10.

Couderc J‑P, Kyal S, Mestha LK et al (2015) Detection of atrial fibrillation using contactless facial video monitoring. Heart Rhythm 12:195–201. https://doi.org/10.1016/j.hrthm.2014.08.035CrossRefPubMed

11.

Diederichsen SZ, Haugan KJ, Kronborg C et al (2020) Comprehensive evaluation of rhythm monitoring strategies in screening for atrial fibrillation. Circulation 141:1510–1522. https://doi.org/10.1161/circulationaha.119.044407CrossRefPubMed

12.

Ding EY, Svennberg E, Wurster C et al (2020) Survey of current perspectives on consumer-available digital health devices for detecting atrial fibrillation. Cardiovasc Digit Health J 1:21–29. https://doi.org/10.1016/j.cvdhj.2020.06.002CrossRefPubMedPubMedCentral

13.

Duncker D, Ding WY, Etheridge S et al (2021) Smart wearables for cardiac monitoring—real-world use beyond atrial fibrillation. Sensors 21:2539. https://doi.org/10.3390/s21072539CrossRefPubMedPubMedCentral

14.

Eerikinen LM, Bonomi AG, Schipper F et al (2019) Detecting atrial fibrillation and atrial flutter in daily life using photoplethysmography data. IEEE J Biomed Health Inform 24:1610–1618. https://doi.org/10.1109/jbhi.2019.2950574CrossRef

15.

Elgendi M, Eskofier B, Dokos S, Abbott D (2014) Revisiting QRS detection methodologies for portable, wearable, battery-operated, and wireless ECG systems. PLoS One 9:e84018. https://doi.org/10.1371/journal.pone.0084018CrossRefPubMedPubMedCentral

16.

Fallet S, Lemay M, Renevey P et al (2019) Can one detect atrial fibrillation using a wrist-type photoplethysmographic device? Med Biol Eng Comput 57:477–487. https://doi.org/10.1007/s11517-018-1886-0CrossRefPubMed

17.

Fouassier D, Roy X, Blanchard A, Hulot J (2020) Assessment of signal quality measured with a smart 12-lead ECG acquisition T‑shirt. Ann Noninvasive Electrocardiol 25:e12682. https://doi.org/10.1111/anec.12682CrossRefPubMed

18.

Freedman B, Schnabel R, Calkins H (2019) Opportunistic electrocardiogram screening for atrial fibrillation to prevent stroke. JAMA Cardiol 4:54–55. https://doi.org/10.1001/jamacardio.2018.4335CrossRef

19.

Fukuma N, Hasumi E, Fujiu K et al (2019) Feasibility of a T-shirt-type wearable electrocardiography monitor for detection of covert atrial fibrillation in young healthy adults. Sci Rep 9:11768. https://doi.org/10.1038/s41598-019-48267-1CrossRefPubMedPubMedCentral

20.

Gawalko M, Duncker D, Manninger M et al (2021) The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences. Europace. https://doi.org/10.1093/europace/euaa394CrossRefPubMedPubMedCentral

21.

Gillinov S, Etiwy M, Wang R et al (2017) Variable accuracy of wearable heart rate monitors during aerobic exercise. Med Sci Sports Exerc 49:1697–1703. https://doi.org/10.1249/mss.0000000000001284CrossRefPubMed

22.

Godin R, Yeung C, Baranchuk A et al (2019) Screening for atrial fibrillation using a mobile, single-lead electrocardiogram in Canadian primary care clinics. Can J Cardiol 35:840–845. https://doi.org/10.1016/j.cjca.2019.03.024CrossRefPubMed

23.

Goldenthal IL, Sciacca RR, Riga T et al (2019) Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results. J Cardiovasc Electrophysiol 30:2220–2228. https://doi.org/10.1111/jce.14160CrossRefPubMedPubMedCentral

24.

Guo Y, Wang H, Zhang H et al (2019) Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 74:2365–2375. https://doi.org/10.1016/j.jacc.2019.08.019CrossRefPubMed

25.

Haberman ZC, Jahn RT, Bose R et al (2015) Wireless smartphone ECG enables large-scale screening in diverse populations. J Cardiovasc Electrophysiol 26:520–526. https://doi.org/10.1111/jce.12634CrossRefPubMed

26.

Halcox JPJ, Wareham K, Cardew A et al (2017) Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation. Circulation 136:1784–1794. https://doi.org/10.1161/circulationaha.117.030583CrossRefPubMed

27.

Han JK, Al-Khatib SM, Albert CM (2020) Changes in the digital health landscape in cardiac electrophysiology: a pre- and peri-pandemic COVID-19 era survey. Cardiovasc Digit Health J. https://doi.org/10.1016/j.cvdhj.2020.12.001CrossRefPubMedPubMedCentral

28.

Heo NJ, Rhee SY, Waalen J, Steinhubl S (2020) Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes. Cardiovasc Diabetol 19:157. https://doi.org/10.1186/s12933-020-01128-yCrossRefPubMedPubMedCentral

29.

Hermans ANL, Velden RMJ, Gawalko M et al (2020) On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation. Clin Cardiol 43:1232–1239. https://doi.org/10.1002/clc.23469CrossRefPubMedPubMedCentral

30.

Hindricks G, Potpara T, Dagres N et al (2020) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS). Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa612CrossRefPubMedPubMedCentral

31.

Jaakkola J, Virtanen R, Vasankari T et al (2017) Self-detection of atrial fibrillation in an aged population: three-year follow-up of the LietoAF intervention study. BMC Geriatr 17:218. https://doi.org/10.1186/s12877-017-0607-0CrossRefPubMedPubMedCentral

32.

Kaleschke G, Hoffmann B, Drewitz I et al (2009) Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Europace 11:1362–1368. https://doi.org/10.1093/europace/eup262CrossRefPubMed

33.

Kearley K, Selwood M, den Bruel AV et al (2014) Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 4:e4565. https://doi.org/10.1136/bmjopen-2013-004565CrossRefPubMedPubMedCentral

34.

Koshy AN, Sajeev JK, Nerlekar N et al (2018) Smart watches for heart rate assessment in atrial arrhythmias. Int J Cardiol 266:124–127. https://doi.org/10.1016/j.ijcard.2018.02.073CrossRefPubMed

35.

Lau JK, Lowres N, Neubeck L et al (2013) iphone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol 165:193–194. https://doi.org/10.1016/j.ijcard.2013.01.220CrossRefPubMed

36.

Li X, Tse VC, Au-Doung LW et al (2016) The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review. Europace. https://doi.org/10.1093/europace/euw093CrossRefPubMedPubMedCentral

37.

Lowres N, Mulcahy G, Gallagher R et al (2016) Self-monitoring for atrial fibrillation recurrence in the discharge period post-cardiac surgery using an iPhone electrocardiogram. Eur J Cardiothorac Surg 50:44–51. https://doi.org/10.1093/ejcts/ezv486CrossRefPubMed

38.

Lowres N, Neubeck L, Salkeld G et al (2014) Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. Thromb Haemost 111:1167–1176. https://doi.org/10.1160/th14-03-0231CrossRefPubMed

39.

Manninger M, Kosiuk J, Zweiker D et al (2020) Role of wearable rhythm recordings in clinical decision making—the wEHRables project. Clin Cardiol 43:1032–1039. https://doi.org/10.1002/clc.23404CrossRefPubMedPubMedCentral

40.

Manninger M, Zweiker D, Svennberg E et al (2021) Current perspectives on wearable rhythm recordings for clinical decision-making: the wEHRAbles 2 survey. Europace. https://doi.org/10.1093/europace/euab064CrossRefPubMedPubMedCentral

41.

McManus DD, Lee J, Maitas O et al (2013) A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart Rhythm 10:315–319. https://doi.org/10.1016/j.hrthm.2012.12.001CrossRefPubMed

42.

Muhlestein JB, Anderson JL, Bethea CF et al (2020) Feasibility of combining serial smartphone single-lead electrocardiograms for the diagnosis of ST-elevation myocardial infarction. Am Heart J 221:125–135. https://doi.org/10.1016/j.ahj.2019.12.016CrossRefPubMed

43.

Murali S, Brugger N, Rincon F et al (2020) Cardiac ambulatory monitoring: new wireless device validated against conventional Holter monitoring in a case series. Front Cardiovasc Med 7:587945. https://doi.org/10.3389/fcvm.2020.587945CrossRefPubMedPubMedCentral

44.

Nemati S, Ghassemi MM, Ambai V et al (2016) Monitoring and detecting atrial fibrillation using wearable technology. Annu Int Conf IEEE Eng Med Biol Soc 2016:3394–3397. https://doi.org/10.1109/embc.2016.7591456CrossRefPubMed

45.

Nguyen HH, Hare GFV, Rudokas M et al (2015) SPEAR trial: smartphone pediatric ElectrocARdiogram trial. PLoS ONE 10:e136256. https://doi.org/10.1371/journal.pone.0136256CrossRefPubMedPubMedCentral

46.

Orchard J, Lowres N, Freedman SB et al (2016) Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): a feasibility study. Eur J Prev Cardiol 23:13–20. https://doi.org/10.1177/2047487316670255CrossRefPubMed

47.

Paradkar N, Chowdhury SR (2017) Cardiac arrhythmia detection using photoplethysmography. Annu Int Conf IEEE Eng Med Biol Soc 2017:113–116. https://doi.org/10.1109/embc.2017.8036775CrossRefPubMed

48.

Perez MV, Mahaffey KW, Hedlin H et al (2019) Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 381:1909–1917. https://doi.org/10.1056/nejmoa1901183CrossRefPubMedPubMedCentral

49.

Pluymaekers NAHA, Hermans ANL, van der Velden RMJ et al (2020) Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF. Europace. https://doi.org/10.1093/europace/euaa201CrossRefPubMedPubMedCentral

50.

Polania LF, Mestha LK, Huang DT, Couderc J‑P (2015) Method for classifying cardiac arrhythmias using photoplethysmography. Annu Int Conf IEEE Eng Med Biol Soc 2015:6574–6577. https://doi.org/10.1109/embc.2015.7319899CrossRefPubMed

51.

Proesmans T, Mortelmans C, Haelst RV et al (2019) Mobile phone–based use of the photoplethysmography technique to detect atrial fibrillation in primary care: diagnostic accuracy study of the Fibricheck app. JMIR Mhealth Uhealth 7:e12284. https://doi.org/10.2196/12284CrossRefPubMedPubMedCentral

52.

Quer G, Freedman B, Steinhubl SR (2020) Screening for atrial fibrillation: predicted sensitivity of short, intermittent electrocardiogram recordings in an asymptomatic at-risk population. Europace 22:euaa186. https://doi.org/10.1093/europace/euaa186CrossRef

53.

Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ (2013) Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol 36:328–333. https://doi.org/10.1111/pace.12053CrossRefPubMed

54.

Samol A, Bischof K, Luani B et al (2019) Single-lead ECG recordings including Einthoven and wilson leads by a smartwatch: a new era of patient directed early ECG differential diagnosis of cardiac diseases? Sensors 19:4377. https://doi.org/10.3390/s19204377CrossRefPubMedCentral

55.

Sarkar S, Ritscher D, Mehra R (2008) A detector for a chronic implantable atrial tachyarrhythmia monitor. IEEE Trans Biomed Eng 55:1219–1224. https://doi.org/10.1109/tbme.2007.903707CrossRefPubMed

56.

Scholz EP, Kehrle F, Vossel S et al (2014) Discriminating atrial flutter from atrial fibrillation using a multilevel model of atrioventricular conduction. Heart Rhythm 11:877–884. https://doi.org/10.1016/j.hrthm.2014.02.013CrossRefPubMed

57.

Siontis KC, Gersh BJ, Killian JM et al (2016) Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm 13:1418–1424. https://doi.org/10.1016/j.hrthm.2016.03.003CrossRefPubMedPubMedCentral

58.

Sološenko A, Petrėnas A, Marozas V (2015) Photoplethysmography-based method for automatic detection of premature ventricular contractions. IEEE Trans Biomed Circuits Syst 9:662–669. https://doi.org/10.1109/tbcas.2015.2477437CrossRefPubMed

59.

Spaich S, Kern H, Zelniker TA et al (2020) Feasibility of CardioSecur®, a mobile 4‑electrode/22-lead ECG device, in the prehospital emergency setting. Front Cardiovasc Med 7:551796. https://doi.org/10.3389/fcvm.2020.551796CrossRefPubMedPubMedCentral

60.

Steinberg C, Philippon F, Sanchez M et al (2019) A novel wearable device for continuous ambulatory ECG recording: proof of concept and assessment of signal quality. Biosensors 9:17. https://doi.org/10.3390/bios9010017CrossRefPubMedCentral

61.

Taggar JS, Coleman T, Lewis S et al (2015) Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol 23:1330–1338. https://doi.org/10.1177/2047487315611347CrossRefPubMedPubMedCentral

62.

Tison GH, Sanchez JM, Ballinger B et al (2018) Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiol 3:409. https://doi.org/10.1001/jamacardio.2018.0136CrossRefPubMedPubMedCentral

63.

Turakhia MP, Hoang DD, Zimetbaum P et al (2013) Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol 112:520–524. https://doi.org/10.1016/j.amjcard.2013.04.017CrossRefPubMed

64.

Varma N, Marrouche NF, Aguinaga L et al (2020) HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic. Europace 23:euaa187. https://doi.org/10.1093/europace/euaa187CrossRef

65.

Verbrugge FH, Proesmans T, Vijgen J et al (2019) Atrial fibrillation screening with photo-plethysmography through a smartphone camera. Europace 21:1167–1175. https://doi.org/10.1093/europace/euz119CrossRefPubMed

66.

Wang R, Blackburn G, Desai M et al (2016) Accuracy of wrist-worn heart rate monitors. JAMA Cardiol 2:104. https://doi.org/10.1001/jamacardio.2016.3340CrossRef

67.

Yan BP, Lai WHS, Chan CKY et al (2018) Contact-free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals. J Am Heart Assoc. https://doi.org/10.1161/jaha.118.008585CrossRefPubMedPubMedCentral

68.

Yan BP, Lai WHS, Chan CKY et al (2020) High-throughput, contact-free detection of atrial fibrillation from video with deep learning. JAMA Cardiol 5:105–107. https://doi.org/10.1001/jamacardio.2019.4004CrossRefPubMed

69.

Zaprutko T, Zaprutko J, Baszko A et al (2019) Feasibility of atrial fibrillation screening with mobile health technologies at pharmacies. J Cardiovasc Pharmacol Ther 25:142–151. https://doi.org/10.1177/1074248419879089CrossRefPubMed

70.

Zink MD, Mischke KG, Keszei AP et al (2020) Screen-detected atrial fibrillation predicts mortality in elderly subjects. Europace 23:euaa190. https://doi.org/10.1093/europace/euaa190CrossRef

Titel: Wearable-basierte Detektion von Arrhythmien
Positionspapier der Deutschen Gesellschaft für Kardiologie
verfasst von: Univ.-Prof. Dr. med. Christian Veltmann
Joachim R. Ehrlich
Ulrich M. Gassner
Benjamin Meder
Martin Möckel
Peter Radke
Eberhard Scholz
Hendrik Schneider
Christoph Stellbrink
David Duncker
Publikationsdatum: 07.07.2021
Verlag: Springer Medizin
Schlagwörter: Herzrhythmusstörungen
Vorhofflimmern
EKG
Herzrhythmusstörungen
EKG
Erschienen in: Die Kardiologie / Ausgabe 4/2021
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI: https://doi.org/10.1007/s12181-021-00488-3

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Vorhofflimmern

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Vorhofflimmern

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Benigner Mitralklappenprolaps oder malignes Mitralklappenprolapssyndrom – Hilft die kardiale MRT bei der Risikoeinschätzung?

Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK)

Kommentar zu den Leitlinien (2020) der ESC zu Sportkardiologie und körperlichem Training für Patienten mit kardiovaskulären Erkrankungen

ESC-Leitlinie Vorhofflimmern – für Sie kommentiert

Postoperative letale rechtsventrikuläre Raumforderung

Metformin – nichtglykämische Wirkungen

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Abbott Structural Heart

Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK)